2026
article
OpenAlex
Connor Jarrett Kinslow, Giuseppe Minniti, Paul David Brown, Michael A. Vogelbaum et autres
PURPOSE Age ≥40 years is regarded as a high-risk feature and an indication for adjuvant chemoradiotherapy for patients with lower-grade glioma in clinical practice guidelines. It is unclear whether age remains a relevant prognostic factor for contemporary definitions of lower-grade gliomas in …
us, it, de, fr
(code pays fourni par la source)
2026
conference-abstract
OpenAlex
Ramzi Homsi, Henry S. Walch, Roshal Patel, Anna Skakodub et autres
Abstract Background: The pan-cancer genomic landscape of brain metastases (BM) has not been well-characterized. Herein, we evaluate genomically profiled BM tumor samples and additional sequenced tumor samples from other sites to further understand disease evolution. Methods: We analyzed BM specimens from 1007 …
us
(code pays fourni par la source)
Accès ouvert
2026
preprint
OpenAlex
Everest Yang, Sparsh Agrawal, Connor Jarrett Kinslow, C. K. et autres
Lower-grade gliomas (World Health Organization [WHO] grades 2-3) exhibit variable treatment responses, yet clinical decisions remain guided by population-level trial results. Standard causal survival forests estimate treatment effects at individual time horizons but lack methodology to synthesize these into interpretable temporal trajectories. …
us
(code pays fourni par la source)
2026
article
OpenAlex
Lauren S Lowe, Dylan K Kim, Christine Hsu Rohde, James B. Yu et autres
Abstract In 2020, the Food and Drug Administration mandated a black box warning on all breast implants, warning of an association with anaplastic large cell lymphoma (ALCL). The World Health Organization recently introduced breast implant–associated anaplastic large cell lymphoma as a new …
us
(code pays fourni par la source)
Accès ouvert
2025
supplementary-materials
OpenAlex
Connor Jarrett Kinslow, Ali I. Rae, Kekoa Taparra, Prashanth Kumar et autres
Supplementary Data
Accès ouvert
2025
supplementary-materials
OpenAlex
Connor Jarrett Kinslow, Ali I. Rae, Kekoa Taparra, Prashanth Kumar et autres
Tables S1-S3
2025
article
OpenAlex
Connor Jarrett Kinslow, Giuseppe Minniti, Paul David Brown, Michael A. Vogelbaum et autres
Abstract PURPOSE Age over 40 years is commonly regarded as a “high risk” feature and potential indication for adjuvant chemoradiotherapy for patients with lower grade glioma in most clinical practice guidelines. However, these recommendations are based on retrospective observations and their subsequent …
us, it, fr, in
(code pays fourni par la source)
Accès ouvert
2025
conference-abstract
OpenAlex
Connor Jarrett Kinslow, David M. DeStephano, Quinn T. Ostrom, Soumyajit Roy et autres
Abstract INTRODUCTION US cancer registries recently started collecting data on brain molecular markers, providing for the first time population-based data on the molecular epidemiology of gliomas. However, the initial release contained a significant proportion of missing data, precluding complete incidence rate estimates. …
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Dylan K Kim, Lauren S Lowe, Alfred I. Neugut, James B. Yu et autres
Importance: The incidence rate of primary breast anaplastic large cell lymphoma (ALCL), a complication associated with breast implants, is rapidly rising in the US. Comprehensive studies on the racial and ethnic epidemiologic characteristics of ALCL in the US are lacking, despite evidence …
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Hassan Mahmood, James B. Yu, David Paul Horowitz, L.A. Kachnic et autres
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Connor Jarrett Kinslow, Dylan K Kim, Lauren S Lowe, Simon K. Cheng et autres
This cohort study evaluates the incidence rate of lymphomas of the breast after implant-based breast reconstruction after cancer-directed mastectomy.
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Dylan K Kim, Lauren S Lowe, Christine Hsu Rohde, David Paul Horowitz et autres
PURPOSE: The US Food and Drug Administration (FDA) recently issued a safety communication for reports of various lymphomas of the breast that developed in association with breast implants and were distinct from BIA-ALCL. We investigate the risk of non-BIA-ALCL breast lymphomas in …
us
(code pays fourni par la source)